ATE192191T1 - Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls - Google Patents

Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls

Info

Publication number
ATE192191T1
ATE192191T1 AT94907760T AT94907760T ATE192191T1 AT E192191 T1 ATE192191 T1 AT E192191T1 AT 94907760 T AT94907760 T AT 94907760T AT 94907760 T AT94907760 T AT 94907760T AT E192191 T1 ATE192191 T1 AT E192191T1
Authority
AT
Austria
Prior art keywords
cell line
pct
producing cell
improved production
fusion protocol
Prior art date
Application number
AT94907760T
Other languages
English (en)
Inventor
Jack Spira
Lars Adamsson
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE192191T1 publication Critical patent/ATE192191T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT94907760T 1993-02-16 1994-02-15 Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls ATE192191T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300509A SE9300509D0 (sv) 1993-02-16 1993-02-16 Peg treatment
PCT/SE1994/000123 WO1994019459A1 (en) 1993-02-16 1994-02-15 Method for obtaining an increased production of a producing celline by using a fusion protocol

Publications (1)

Publication Number Publication Date
ATE192191T1 true ATE192191T1 (de) 2000-05-15

Family

ID=20388915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94907760T ATE192191T1 (de) 1993-02-16 1994-02-15 Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls

Country Status (14)

Country Link
US (1) US5607845A (de)
EP (1) EP0684992B1 (de)
JP (1) JPH08509363A (de)
AT (1) ATE192191T1 (de)
AU (1) AU671195B2 (de)
CA (1) CA2156181C (de)
DE (1) DE69424153T2 (de)
DK (1) DK0684992T3 (de)
ES (1) ES2147781T3 (de)
GR (1) GR3034006T3 (de)
NZ (1) NZ261936A (de)
PT (1) PT684992E (de)
SE (1) SE9300509D0 (de)
WO (1) WO1994019459A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9303601D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Improved cell cultivation method and medium
US10329594B1 (en) * 2015-09-03 2019-06-25 CHO Plus, Inc. Cell lines for high level production of protein-based pharmaceuticals
US11649449B2 (en) 2015-09-03 2023-05-16 CHO Plus, Inc. Hybrid cell lines for high level production of a target protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659663A (en) * 1984-10-01 1987-04-21 Board Of Regents, University Of Texas System Methods for isolating cell fusion products
US4822470A (en) * 1987-10-09 1989-04-18 Baylor College Of Medicine Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses
US4832814A (en) * 1987-12-28 1989-05-23 E. I. Du Pont De Nemours And Company Electrofusion cell and method of making the same
GB8807271D0 (en) * 1988-03-26 1988-04-27 Preece A W Cell fusion apparatus
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
SE468050C (sv) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII

Also Published As

Publication number Publication date
EP0684992B1 (de) 2000-04-26
AU6119794A (en) 1994-09-14
GR3034006T3 (en) 2000-11-30
SE9300509D0 (sv) 1993-02-16
DK0684992T3 (da) 2000-09-18
PT684992E (pt) 2000-10-31
AU671195B2 (en) 1996-08-15
DE69424153T2 (de) 2000-11-16
ES2147781T3 (es) 2000-10-01
CA2156181A1 (en) 1994-09-01
NZ261936A (en) 1996-05-28
US5607845A (en) 1997-03-04
CA2156181C (en) 2004-09-21
JPH08509363A (ja) 1996-10-08
DE69424153D1 (de) 2000-05-31
EP0684992A1 (de) 1995-12-06
WO1994019459A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
US4604234A (en) Protein having cell growth stimulating action, composition thereof and method for producing the same
DE69333433D1 (de) Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
ATE123925T1 (de) Verfahren zur herstellung eines enzymhydrolysates.
TR199701543T1 (xx) Memelilerde h�cre k�lt�rlerinin �retti�i proteinlerin sialilasyonunun kontrol�
LU90855I2 (en) Proteine 1 osteogenique recombinante humaine: bmp-7 et ses d-riv-s pharmaceutiquement acceptables
ATE330002T1 (de) Verfahren zur herstellung von membranvesikeln
EP0400958A3 (de) Lebende Impfstoffe
DK0764209T3 (da) Albuminekspression i gær
DE69635924D1 (de) Isolierung und züchtung von schwannzellen
DE69736391D1 (de) Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines hemmstoffes einer metallabhängigen protease oder chymotrypsins zum zellkulturmedium
DE58905236D1 (de) Verfahren zur modifizierung von molke.
DE69231995D1 (de) Verfahren zur Herstellung/Sekretion eines Proteins durch einen transformiertenSchimmelpilz unter Verwendung von Expressions-/Sekretions- Regulationsregionenaus Aspergillus
ATE169641T1 (de) Verfahren zur herstellung von stärkeabbauprodukten
DE59913565D1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
CN106563173A (zh) 一种脱细胞生物真皮材料及其制备方法和应用
ATE280222T1 (de) Alkaline protease, verfahren zu ihrer herstellung,anwendung derselben und diese herstellende mikroorganismen
ATE192191T1 (de) Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls
ATE342062T1 (de) Angiotensin ii zur verbesserung der befruchtung
ATE218162T1 (de) Ketogruppe-einführendes enzym, dafür kodierende dna und verfahren zur herstellung von ketocarotenoid
DE59607050D1 (de) Verfahren zur herstellung von riboflavin mittels mikroorganismen mit veränderter isocitratlyase-aktivität
EP0770137A4 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
DE69535126D1 (de) Verfahren zur herstellung von sekundären metaboliten
ATE168117T1 (de) Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung
DE69528183D1 (de) Verfahren zur herstellung eines brotaufstrichs
DE68913212D1 (de) Ein reines faktor i-protein und verfahren zur herstellung.